Logo image
Antiplatelet regimens following carotid artery revascularization
Journal article   Peer reviewed

Antiplatelet regimens following carotid artery revascularization

Megan Lee, Zain V Ahmed, Jiaming Huang, Aaron Brice, Ahmad Arham, Yulanka Castro-Dominguez, Edouard Aboian, Sameer Nagpal, Kim G Smolderen and Carlos Mena-Hurtado
The American heart journal, Vol.253, pp.48-52
11/2022
DOI: 10.1016/j.ahj.2022.07.004
PMID: 35863439

View Online

Abstract

Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative New England data, we found that of 12,257 patients, 82% patients were discharged on DAPT following CAS and 66% were discharged on SAPT following CEA. While a high percentage of patients undergoing CAS appropriately receive DAPT, the use of SAPT following CEA exists with more variability and lower adherence rates.
Carotid Arteries Carotid Stenosis - surgery Endarterectomy, Carotid Humans Platelet Aggregation Inhibitors - therapeutic use Retrospective Studies Risk Factors Stents Stroke - drug therapy Treatment Outcome

Details

Metrics

1 Record Views
Logo image